Post transplant lymphoproliferative disorder

WikiDoc Resources for Post transplant lymphoproliferative disorder
Articles
Most recent articles on Post transplant lymphoproliferative disorder Most cited articles on Post transplant lymphoproliferative disorder Review articles on Post transplant lymphoproliferative disorder Articles on Post transplant lymphoproliferative disorder in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Post transplant lymphoproliferative disorder Images of Post transplant lymphoproliferative disorder Photos of Post transplant lymphoproliferative disorder Podcasts & MP3s on Post transplant lymphoproliferative disorder Videos on Post transplant lymphoproliferative disorder
Evidence Based Medicine
Cochrane Collaboration on Post transplant lymphoproliferative disorder Bandolier on Post transplant lymphoproliferative disorder TRIP on Post transplant lymphoproliferative disorder
Clinical Trials
Ongoing Trials on Post transplant lymphoproliferative disorder at Clinical Trials.gov Trial results on Post transplant lymphoproliferative disorder Clinical Trials on Post transplant lymphoproliferative disorder at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Post transplant lymphoproliferative disorder NICE Guidance on Post transplant lymphoproliferative disorder NHS PRODIGY Guidance FDA on Post transplant lymphoproliferative disorder CDC on Post transplant lymphoproliferative disorder
Books
Books on Post transplant lymphoproliferative disorder
News
Post transplant lymphoproliferative disorder in the news Be alerted to news on Post transplant lymphoproliferative disorder News trends on Post transplant lymphoproliferative disorder
Commentary
Blogs on Post transplant lymphoproliferative disorder
Definitions
Definitions of Post transplant lymphoproliferative disorder
Patient Resources / Community
Patient resources on Post transplant lymphoproliferative disorder Discussion groups on Post transplant lymphoproliferative disorder Patient Handouts on Post transplant lymphoproliferative disorder Directions to Hospitals Treating Post transplant lymphoproliferative disorder Risk calculators and risk factors for Post transplant lymphoproliferative disorder
Healthcare Provider Resources
Symptoms of Post transplant lymphoproliferative disorder Causes & Risk Factors for Post transplant lymphoproliferative disorder Diagnostic studies for Post transplant lymphoproliferative disorder Treatment of Post transplant lymphoproliferative disorder
Continuing Medical Education (CME)
CME Programs on Post transplant lymphoproliferative disorder
International
Post transplant lymphoproliferative disorder en Espanol Post transplant lymphoproliferative disorder en Francais
Business
Post transplant lymphoproliferative disorder in the Marketplace Patents on Post transplant lymphoproliferative disorder
Experimental / Informatics
List of terms related to Post transplant lymphoproliferative disorder

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Your Name

Synonyms and keywords: Synonym 1; Synonym 2; Synonym 3

Historical Perspective

• Post transplant lymphoproliferative disorder was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
• In [year], [gene] mutations were first identified in the pathogenesis of post transplant lymphoproliferative disorder.
• In [year], the first [discovery] was developed by [scientist] to treat/diagnose post transplant lymphoproliferative disorder.

Classification

• Post transplant lymphoproliferative disorder may be classified according to [classification method] into [number] subtypes/groups:

• [group1]
• [group2]
• [group3]

• Other variants of post transplant lymphoproliferative disorder include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

Pathophysiology

• The pathogenesis of post transplant lymphoproliferative disorder is characterized by [feature1], [feature2], and [feature3].
• The [gene name] gene/Mutation in [gene name] has been associated with the development of post transplant lymphoproliferative disorder, involving the [molecular pathway] pathway.
• On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of post transplant lymphoproliferative disorder.
• On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of post transplant lymphoproliferative disorder.

Causes

• Post transplant lymphoproliferative disorder may be caused by either [cause1], [cause2], or [cause3].
• Post transplant lymphoproliferative disorder is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
• There are no established causes for post transplant lymphoproliferative disorder.

Differentiating post transplant lymphoproliferative disorder from other Diseases

• Post transplant lymphoproliferative disorder must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

• [Differential dx1]
• [Differential dx2]
• [Differential dx3]

Epidemiology and Demographics

• The prevalence of post transplant lymphoproliferative disorder is approximately [number or range] per 100,000 individuals worldwide.
• In [year], the incidence of post transplant lymphoproliferative disorder was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

• Patients of all age groups may develop post transplant lymphoproliferative disorder.

• Post transplant lymphoproliferative disorder is more commonly observed among patients aged [age range] years old.
• Post transplant lymphoproliferative disorder is more commonly observed among [elderly patients/young patients/children].

Gender

• Post transplant lymphoproliferative disorder affects men and women equally.

• [Gender 1] are more commonly affected with post transplant lymphoproliferative disorder than [gender 2].
• The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

• There is no racial predilection for post transplant lymphoproliferative disorder.

• Post transplant lymphoproliferative disorder usually affects individuals of the [race 1] race.
• [Race 2] individuals are less likely to develop post transplant lymphoproliferative disorder.

Risk Factors

• Common risk factors in the development of post transplant lymphoproliferative disorder are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

• The majority of patients with post transplant lymphoproliferative disorder remain asymptomatic for [duration/years].
• Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
• If left untreated, [#%] of patients with post transplant lymphoproliferative disorder may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
• Common complications of post transplant lymphoproliferative disorder include [complication 1], [complication 2], and [complication 3].
• Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with post transplant lymphoproliferative disorder is approximately [#%].

Diagnosis

Diagnostic Criteria

• The diagnosis of post transplant lymphoproliferative disorder is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms

• Post transplant lymphoproliferative disorder is usually asymptomatic.
• Symptoms of post transplant lymphoproliferative disorder may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Patients with post transplant lymphoproliferative disorder usually appear [general appearance].
• Physical examination may be remarkable for:

• [finding 1]
• [finding 2]
• [finding 3]
• [finding 4]
• [finding 5]
• [finding 6]

Laboratory Findings

• There are no specific laboratory findings associated with post transplant lymphoproliferative disorder.

• A [positive/negative] [test name] is diagnostic of post transplant lymphoproliferative disorder.
• An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of post transplant lymphoproliferative disorder.
• Other laboratory findings consistent with the diagnosis of post transplant lymphoproliferative disorder include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings

• There are no [imaging study] findings associated with post transplant lymphoproliferative disorder.

• [Imaging study 1] is the imaging modality of choice for post transplant lymphoproliferative disorder.
• On [imaging study 1], post transplant lymphoproliferative disorder is characterized by [finding 1], [finding 2], and [finding 3].
• [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

• Post transplant lymphoproliferative disorder may also be diagnosed using [diagnostic study name].
• Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

• There is no treatment for post transplant lymphoproliferative disorder; the mainstay of therapy is supportive care.

• The mainstay of therapy for post transplant lymphoproliferative disorder is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

• Surgery is the mainstay of therapy for post transplant lymphoproliferative disorder.
• [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of post transplant lymphoproliferative disorder.
• [Surgical procedure] can only be performed for patients with [disease stage] post transplant lymphoproliferative disorder.

Prevention

• There are no primary preventive measures available for post transplant lymphoproliferative disorder.

• Effective measures for the primary prevention of post transplant lymphoproliferative disorder include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with post transplant lymphoproliferative disorder are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].